Recently, it has been discovered that high HK2 expression is associated with a poor prognosis and endpoint of cancer in several tumors, indicating that HK2 is a possible therapeutic target for cancer (Ros and Schulze, 2013; Katagiri et al., 2017; Zhou et al., 2019). Here, HK2 is linked to cancer.